These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 16818925)

  • 1. The effect of including C-reactive protein in cardiovascular risk prediction models for women.
    Cook NR; Buring JE; Ridker PM
    Ann Intern Med; 2006 Jul; 145(1):21-9. PubMed ID: 16818925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score.
    Ridker PM; Buring JE; Rifai N; Cook NR
    JAMA; 2007 Feb; 297(6):611-9. PubMed ID: 17299196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Summaries for patients. C-reactive protein and prediction of risk for cardiovascular disease in women.
    Ann Intern Med; 2006 Jul; 145(1):I19. PubMed ID: 16818922
    [No Abstract]   [Full Text] [Related]  

  • 4. Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women.
    Ridker PM; Rifai N; Cook NR; Bradwin G; Buring JE
    JAMA; 2005 Jul; 294(3):326-33. PubMed ID: 16030277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men.
    Ridker PM; Paynter NP; Rifai N; Gaziano JM; Cook NR
    Circulation; 2008 Nov; 118(22):2243-51, 4p following 2251. PubMed ID: 18997194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women.
    Everett BM; Kurth T; Buring JE; Ridker PM
    J Am Coll Cardiol; 2006 Dec; 48(11):2235-42. PubMed ID: 17161253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of Lipoprotein-Associated Phospholipase A
    Tibuakuu M; Kianoush S; DeFilippis AP; McEvoy JW; Zhao D; Guallar E; Ballantyne CM; Hoogeveen RC; Blaha MJ; Michos ED
    Am J Cardiol; 2018 May; 121(9):1056-1064. PubMed ID: 29525060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease.
    Ridker PM
    Circulation; 2001 Apr; 103(13):1813-8. PubMed ID: 11282915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus.
    Ridker PM
    J Am Coll Cardiol; 2007 May; 49(21):2129-38. PubMed ID: 17531663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.
    Ridker PM; Danielson E; Fonseca FA; Genest J; Gotto AM; Kastelein JJ; Koenig W; Libby P; Lorenzatti AJ; Macfadyen JG; Nordestgaard BG; Shepherd J; Willerson JT; Glynn RJ;
    Lancet; 2009 Apr; 373(9670):1175-82. PubMed ID: 19329177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification and prognostic implication of plasma biomarkers in nondiabetic patients with stable coronary artery disease: the role of high-sensitivity C-reactive protein.
    Leu HB; Lin CP; Lin WT; Wu TC; Chen JW
    Chest; 2004 Oct; 126(4):1032-9. PubMed ID: 15486359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.
    Ridker PM; Rifai N; Rose L; Buring JE; Cook NR
    N Engl J Med; 2002 Nov; 347(20):1557-65. PubMed ID: 12432042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel and conventional biomarkers for prediction of incident cardiovascular events in the community.
    Melander O; Newton-Cheh C; Almgren P; Hedblad B; Berglund G; Engström G; Persson M; Smith JG; Magnusson M; Christensson A; Struck J; Morgenthaler NG; Bergmann A; Pencina MJ; Wang TJ
    JAMA; 2009 Jul; 302(1):49-57. PubMed ID: 19567439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal and nutritional effects on cardiovascular risk markers in young women.
    Lawson EA; Miller KK; Mathur VA; Misra M; Meenaghan E; Herzog DB; Klibanski A
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3089-94. PubMed ID: 17519306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-sensitivity C-reactive protein is only weakly related to cardiovascular damage after adjustment for traditional cardiovascular risk factors.
    Olsen MH; Christensen MK; Hansen TW; Gustafsson F; Rasmussen S; Wachtell K; Borch-Johnsen K; Ibsen H; Jørgensen T; Hildebrandt P
    J Hypertens; 2006 Apr; 24(4):655-61. PubMed ID: 16531793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct Versus Calculated LDL Cholesterol and C-Reactive Protein in Cardiovascular Disease Risk Assessment in the Framingham Offspring Study.
    Ikezaki H; Fisher VA; Lim E; Ai M; Liu CT; Adrienne Cupples L; Nakajima K; Asztalos BF; Furusyo N; Schaefer EJ
    Clin Chem; 2019 Sep; 65(9):1102-1114. PubMed ID: 31239251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein, fibrinogen, and cardiovascular disease prediction.
    ; Kaptoge S; Di Angelantonio E; Pennells L; Wood AM; White IR; Gao P; Walker M; Thompson A; Sarwar N; Caslake M; Butterworth AS; Amouyel P; Assmann G; Bakker SJ; Barr EL; Barrett-Connor E; Benjamin EJ; Björkelund C; Brenner H; Brunner E; Clarke R; Cooper JA; Cremer P; Cushman M; Dagenais GR; D'Agostino RB; Dankner R; Davey-Smith G; Deeg D; Dekker JM; Engström G; Folsom AR; Fowkes FG; Gallacher J; Gaziano JM; Giampaoli S; Gillum RF; Hofman A; Howard BV; Ingelsson E; Iso H; Jørgensen T; Kiechl S; Kitamura A; Kiyohara Y; Koenig W; Kromhout D; Kuller LH; Lawlor DA; Meade TW; Nissinen A; Nordestgaard BG; Onat A; Panagiotakos DB; Psaty BM; Rodriguez B; Rosengren A; Salomaa V; Kauhanen J; Salonen JT; Shaffer JA; Shea S; Ford I; Stehouwer CD; Strandberg TE; Tipping RW; Tosetto A; Wassertheil-Smoller S; Wennberg P; Westendorp RG; Whincup PH; Wilhelmsen L; Woodward M; Lowe GD; Wareham NJ; Khaw KT; Sattar N; Packard CJ; Gudnason V; Ridker PM; Pepys MB; Thompson SG; Danesh J
    N Engl J Med; 2012 Oct; 367(14):1310-20. PubMed ID: 23034020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation, C-reactive protein, and atherothrombosis.
    Ridker PM; Silvertown JD
    J Periodontol; 2008 Aug; 79(8 Suppl):1544-51. PubMed ID: 18673009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Test in Context: High-Sensitivity C-Reactive Protein.
    Ridker PM
    J Am Coll Cardiol; 2016 Feb; 67(6):712-723. PubMed ID: 26868696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between High-Sensitivity C-Reactive Protein and Total Stroke by Hypertensive Status Among Men.
    Jiménez MC; Rexrode KM; Glynn RJ; Ridker PM; Gaziano JM; Sesso HD
    J Am Heart Assoc; 2015 Sep; 4(9):e002073. PubMed ID: 26391131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.